Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 18:16:43 - browse：52

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Cassava reveals details — and problems — with Alzheimer's study

focus

WSS

CDC recommends rationing of RSV shot due to shortages

Telehealth options flood the market as retailers push virtual care

Testing for cancer recurrence creates a new limbo for patients

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

First Opinion Podcast: How to protect health care in times of war

Chimpanzees, like humans and whales, get menopause: Study

focus

Wikipedia

focus

At least 13 dead in Texas as scorching temps continue

Orangutan used medicinal plant to treat wound, first time ever seen

Medicare details structure of new drug price negotiation program

Why Sanofi got shellacked over its spinoff

In age of alternative facts, a scholarly course on calling out crap

Dogs on Prozac: What pet anti

Jerome Adams on the need for new antivirals for Covid

CDC recommends rationing of RSV shot due to shortages

Medical leaders decry Supreme Court decision on affirmative action

Biden's order seeks to regulate AI risk without stifling innovation

focus

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

First Opinion Podcast: How to protect health care in times of war

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: XBI biotech index, Akero Therapeutics

H5N1 bird flu found in pasteurized milk: what we know

Cancer researcher Catriona Jamieson is sending tumors into space

focus

hotspot

knowledge

leisure time